|
|
| | ACT 709478 Basic information |
| Product Name: | ACT 709478 | | Synonyms: | ACT 709478;ACT-709478 1838651-58-3;Benzeneacetamide, N-[1-[(5-cyano-2-pyridinyl)methyl]-1H-pyrazol-3-yl]-4-[1-(trifluoromethyl)cyclopropyl]-;ACT 709478
(ACT709478);apinocaltamide;N-(1-((5-Cyanopyridin-2-yl)methyl)-1H-pyrazol-3-yl)-2-(4-(1-(trifluoromethyl)cyclopropyl)phenyl)acetamide | | CAS: | 1838651-58-3 | | MF: | C22H18F3N5O | | MW: | 425.41 | | EINECS: | | | Product Categories: | | | Mol File: | 1838651-58-3.mol |  |
| | ACT 709478 Chemical Properties |
| Boiling point | 646.4±55.0 °C(Predicted) | | density | 1.36±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO:125.0(Max Conc. mg/mL);293.83(Max Conc. mM) | | form | A solid | | pka | 13.52±0.70(Predicted) |
| | ACT 709478 Usage And Synthesis |
| Definition | ChEBI: Apinocaltamide is a secondary carboxamide resulting from the formal condensation of the carboxy group of {4-[1-(trifluoromethyl)cyclopropyl]phenyl}acetic acid with the amino group of 6-[(3-amino-1H-pyrazol-1-yl)methyl]pyridine-3-carbonitrile. It is a selective, orally available T-type calcium channel blocker that is being studied as a potential new treatment in epilepsy. It has a role as an anticonvulsant and a T-type calcium channel blocker. It is a member of pyrazoles, a secondary carboxamide, a member of cyclopropanes, an organofluorine compound, a nitrile, a member of pyridines and a member of benzenes. |
| | ACT 709478 Preparation Products And Raw materials |
|